InvestorsHub Logo
Followers 6
Posts 530
Boards Moderated 0
Alias Born 07/14/2014

Re: Backstabbed post# 559

Wednesday, 11/14/2018 8:53:17 AM

Wednesday, November 14, 2018 8:53:17 AM

Post# of 5716
Can someone tell me what the primary endpoint was that they missed. I was told that they were short by 1 or 2 clinical trials? I was also told that the product does work and it will be FDA approved shortly. If this is true, the stock will go back over $2 quickly then continue to rise for a long time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News